Mouse Anti-ICOS Recombinant Antibody (CBYY-I0689) (CBMAB-I1519-YY)

Name: Mouse Anti-ICOS Recombinant Antibody (CBYY-I0689)
SKU: CBMAB-I1519-YY
Rating: 5 (1 reviews)

See all ICOS antibodies

Compare Online Inquiry

Datasheet

SDS

Request for COA

Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Host Animal

Mouse

Clone

CBYY-I0689

Application

FC, BL, CyTOF

Specificity

Human

Antibody Isotype

IgG1

Clonality

Monoclonal

Application Notes

The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format

Liquid

Storage

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

More Infomation

Target

Full Name

Inducible T Cell Costimulator

Introduction

The protein encoded by this gene belongs to the CD28 and CTLA-4 cell-surface receptor family. It forms homodimers and plays an important role in cell-cell signaling, immune responses, and regulation of cell proliferation.

Entrez Gene ID

29851

UniProt ID

Q9Y6W8

Alternative Names

Inducible T Cell Costimulator

Function

Enhances all basic T-cell responses to a foreign antigen, namely proliferation, secretion of lymphokines, up-regulation of molecules that mediate cell-cell interaction, and effective help for antibody secretion by B-cells. Essential both for efficient interaction between T and B-cells and for normal antibody responses to T-cell dependent antigens. Does not up-regulate the production of interleukin-2, but superinduces the synthesis of interleukin-10. Prevents the apoptosis of pre-activated T-cells. Plays a critical role in CD40-mediated class switching of immunoglobin isotypes (By similarity).

Biological Process

Cell-cell adhesion Source: GO_Central
Immune response Source: UniProtKB
T cell costimulation Source: GO_Central
T cell tolerance induction Source: GO_Central

Cellular Location

Isoform 1: Cell membrane
Isoform 2: Secreted

Involvement in disease

Immunodeficiency, common variable, 1 (CVID1):
A primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B-cells is usually in the normal range, but can be low.

Topology

Extracellular: 21-140
Helical: 141-161
Cytoplasmic: 162-199

PTM

N-glycosylated.

Chavez, J. C., Foss, F. M., William, B. M., Brammer, J. E., Smith, S. M., Prica, A., ... & Siu, L. L. (2023). Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma. Clinical Cancer Research, 29(10), 1869-1878.

Boggio, E., Gigliotti, C. L., Moia, R., Scotta, A., Crespi, I., Boggione, P., ... & Dianzani, U. (2022). Inducible T‐cell co‐stimulator (ICOS) and ICOS ligand are novel players in the multiple‐myeloma microenvironment. British Journal of Haematology, 196(6), 1369-1380.

Di Raimondo, C., Rubio‐Gonzalez, B., Palmer, J., Weisenburger, D. D., Zain, J., Wu, X., ... & Querfeld, C. (2022). Expression of immune checkpoint molecules programmed death protein 1, programmed death‐ligand 1 and inducible T‐cell co‐stimulator in mycosis fungoides and Sézary syndrome: association with disease stage and clinical outcome. British Journal of Dermatology, 187(2), 234-243.

Ramavath, N. N., Gadipudi, L. L., Provera, A., Gigliotti, L. C., Boggio, E., Bozzola, C., ... & Sutti, S. (2021). Inducible T-cell costimulator mediates lymphocyte/macrophage interactions during liver repair. Frontiers in Immunology, 12, 786680.

Raineri, D., Cappellano, G., Vilardo, B., Maione, F., Clemente, N., Canciani, E., ... & Chiocchetti, A. (2021). Inducible T-cell costimulator ligand plays a dual role in melanoma metastasis upon binding to osteopontin or inducible T-cell costimulator. Biomedicines, 10(1), 51.

Solinas, C., Gu-Trantien, C., & Willard-Gallo, K. (2020). The rationale behind targeting the ICOS-ICOS ligand costimulatory pathway in cancer immunotherapy. ESMO open, 5(1), e000544.

Rischin, D., Groenland, S. L., Lim, A. M. L., Martin-Liberal, J., Moreno, V., Perez, J. T., ... & Angevin, E. (2019). Inducible T cell costimulatory (ICOS) receptor agonist, GSK3359609 (GSK609) alone and in combination with pembrolizumab (pembro): Preliminary results from INDUCE-1 expansion cohorts (EC) in head and neck squamous cell carcinoma (HNSCC). Annals of Oncology, 30, v454-v455.

Panneton, V., Chang, J., Witalis, M., Li, J., & Suh, W. K. (2019). Inducible T‐cell co‐stimulator: signaling mechanisms in T follicular helper cells and beyond. Immunological Reviews, 291(1), 91-103.

Zhang, M., Wu, Y., Bastian, D., Iamsawat, S., Chang, J., Daenthanasanmak, A., ... & Yu, X. Z. (2018). Inducible T-cell co-stimulator impacts chronic graft-versus-host disease by regulating both pathogenic and regulatory T cells. Frontiers in Immunology, 9, 1461.

Amatore, F., Gorvel, L., & Olive, D. (2018). Inducible Co-Stimulator (ICOS) as a potential therapeutic target for anti-cancer therapy. Expert opinion on therapeutic targets, 22(4), 343-351.

Ask a question We look forward to hearing from you.

0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Have you used Mouse Anti-ICOS Recombinant Antibody (CBYY-I0689)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

$30 eGift Card
Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols

Related Products

Rat Anti-ICOS Recombinant Antibody (7E.17G9) (CAT#: CBMAB-1019-LY)

Mouse Anti-ICOS Recombinant Antibody (CBYY-I0758) (CAT#: CBMAB-I1685-YY)

Rat Anti-ICOS Recombinant Antibody (CBFYC-0343) (CAT#: CBMAB-C0382-FY)

Human Anti-ICOS Recombinant Antibody (CBXC-0734) (CAT#: CBMAB-C1848-CQ)

Mouse Anti-ICOS Recombinant Antibody (CBYY-I0795) (CAT#: CBMAB-I1772-YY)

Mouse Anti-ICOS Recombinant Antibody (ISA-3) (CAT#: CBMAB-C2955WJ)

Mouse Anti-ICOS Recombinant Antibody (CBWJC-2182) (CAT#: CBMAB-C2952WJ)

Rabbit Anti-ICOS Recombinant Antibody (SP98) (CAT#: CBMAB-I1087-YY)

Rat Anti-ICOS Recombinant Antibody (670306) (CAT#: CBMAB-I1520-YY)

Hamster Anti-ICOS Recombinant Antibody (27A12) (CAT#: CBMAB-I0231-YY)

Isotype control

For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Request bulk or custom quote Second antibody and isotype control

Contact us

Tel: (USA)
(UK)
Fax:

Global Locations

Email:

Online Inquiry